Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine as a Demethylating Agent in Rectal Cancer
NCT00575640Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Nov 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hydralazine in rectal cancer, sponsored by University of Arkansas. Planned start Nov 2004; status: withdrawn.
02
Drugs
hydralazine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00575640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575640.